Status: current, Defined. Date: 31-Jul 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1657231000168112 | Tobramycin (AN) (tobramycin 300 mg / 5 mL) inhalation solution, 56 x 5 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1657241000168115 | Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Is a | tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | has TPUU | Tobramycin (AN) 300 mg/5 mL inhalation solution, 5 mL ampoule | true | Inferred relationship | Some | 1 | |
| Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | has TP | Tobramycin (AN) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Is a | True | Tobramycin (AN) 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR